MedTrace Logo

Zinc & Bone Health in Thalassemia: The Think Zinc Study

NCT00459732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2020-12-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test whether zinc can improve bone health in young patients with thalassemia.

Conditions

Interventions

DIETARY_SUPPLEMENT

Zinc

25 mg of elemental zinc as zinc sulphate take once daily for 18 months

DIETARY_SUPPLEMENT

Placebo

Placebo capsule, identical to the zn capsule in size, shape and color, taken once daily for 18 months

Sponsors & Collaborators

Principal Investigators

  • Ellen B. Fung, PhD, RD · UCSF Benioff Children's Hospital Oakland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2009-10-31
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459732 on ClinicalTrials.gov